Menopause Headaches and Migraines: Causes and Relief
Dr. Karla Loken is a board-certified OB/GYN with over two decades of clinical experience and a distinguished career driving innovation in women's health across the pharmaceutical, diagnostics, and medical device industries. Through her consultancy, Loken & Associates, Dr. Loken provides medical affairs expertise and fractional Chief Medical Officer (CMO) services, helping early-stage companies bridge the gap between scientific innovation and industry application. She serves as Chief Medical Officer to MenoHealth. · 11 min read · Sep 2026
Medically reviewed by Karla F. Loken, DO, FACOOG on September 20, 2026

Menopause headaches and migraines: why perimenopause is volatile, why postmenopause often quiets things, and what helps — including the HRT nuance.
I've had problems with perimenopause. And no one's taking me seriously. I'm seeing doctor after doctor and I'm not getting any relief. The same story, over and over again — in real life and on social media.
If you’ve noticed your headaches changing during your 40s or early 50s — getting worse, getting better, changing character, or showing up for the first time in years — you’re observing a well-documented pattern. Menopause headaches are not a single phenomenon. Perimenopause is one of the most volatile periods for headache and migraine in many women’s lives; postmenopause, for many, is one of the quietest.
This guide walks through what’s actually happening with headaches and migraines across the menopause transition, what helps and what doesn’t, and when a headache pattern warrants prompt evaluation rather than self-management.
Key takeaways
Migraines often worsen during perimenopause due to estrogen fluctuation, then frequently improve in postmenopause as hormone levels stabilize.
Tension-type headaches can increase during the transition driven by sleep disruption, mood symptoms, and muscle tension.
Hormone therapy can help or worsen headaches depending on formulation, route of administration, and your specific migraine pattern; transdermal estrogen with stable dosing is generally preferred for women with a history of migraine.
Migraine with aura is associated with increased stroke risk, and that risk is amplified by oral combined estrogen-progestin contraceptives — important when discussing perimenopausal treatment options.
Sudden severe headache, new neurological symptoms, or any “worst headache ever” should be evaluated urgently.
Why headaches change during the menopause transition
Estrogen has powerful effects on the brain’s vascular and pain-processing systems. Estrogen modulates serotonin levels, influences blood vessel reactivity, and shapes inflammatory pathways involved in headache generation. The dramatic fluctuation of estrogen during perimenopause — rather than the eventual lower level — is what drives much of the change in headache pattern that women experience.
Migraines are particularly sensitive to estrogen fluctuation. Many women with menstrual migraine recognize the pattern of headaches clustered around the estrogen drop of the late luteal and early follicular phases. During perimenopause, those drops happen more often and less predictably, and many women experience an increase in migraine frequency, severity, or both. In postmenopause, estrogen levels stabilize at a lower baseline, and for many women with previously hormone-sensitive migraine, attacks become less frequent.
Tension-type headaches are driven less by hormones directly and more by their downstream effects: sleep disruption from hot flushes and night sweats, mood symptoms (anxiety and depression both increase headache vulnerability), and the muscle tension that accumulates with stress and poor sleep. The increase in tension-type headaches that many women report during perimenopause largely tracks these contributors.
New-onset headaches in midlife deserve closer attention. Headaches that begin for the first time after age 50, change character meaningfully, or develop new features warrant clinical evaluation rather than attribution to menopause.
How menopause headaches typically pattern
A few characteristic patterns help distinguish menopause-related headaches from other causes:
Worsening during perimenopause and improvement in postmenopause is the most common migraine trajectory
Increased headache frequency around vasomotor symptom clusters points to the sleep-disruption pathway
Headaches accompanying hot flushes or night sweats often resolve when the vasomotor symptoms are treated
Headaches around remaining periods persist in the perimenopausal years and tend to ease as cycles stop
Headaches that emerge or worsen after starting oral hormonal contraception suggest hormonal sensitivity
Improvement after switching from oral to transdermal estrogen is common in women with previously worsened headaches on hormone therapy
What helps
The brain is exquisitely sensitive to estrogen and progesterone. It's had these hormones in a particular pattern its whole life, and now that pattern is broken. That's not a character flaw. That's physiology.
The evidence-based approach to menopause headaches depends on the headache type, the broader symptom picture, and your candidacy for hormone therapy.
Treat the contributors
Sleep disruption, mood symptoms, and vasomotor symptoms all increase headache frequency. Treating each — through CBT for insomnia, hormone therapy or non-hormonal options for hot flushes, and appropriate management of anxiety or depression — often produces meaningful headache improvement as a secondary effect. Our menopause insomnia and menopause anxiety guides cover these in more detail.
Hormone therapy: a nuanced picture
Hormone therapy has a complex relationship with headaches. For women with previously hormone-sensitive migraine, the steady estrogen levels delivered by transdermal estrogen (patches, gels, sprays) often reduce migraine frequency by eliminating the cyclic estrogen drops that triggered attacks. Oral estrogen produces more variable serum levels and is less reliably helpful — sometimes worsening headaches.
A practical approach for women with migraine who are candidates for hormone therapy: transdermal estrogen at a stable dose, with progestogen delivered separately if a uterus is present. The Menopause Society 2022 Hormone Therapy Position Statement and NICE Guideline NG23 cover candidacy and route selection.
Migraine with aura changes the calculus. The combination of migraine with aura and oral combined estrogen-progestin contraceptives is associated with increased ischemic stroke risk. Menopausal hormone therapy uses lower estrogen doses than combined contraceptives, and transdermal delivery further reduces the procoagulant risk — so most guidelines do not consider migraine with aura an absolute contraindication to transdermal menopausal hormone therapy. This is a conversation worth having with a clinician who knows the current evidence rather than relying on older blanket guidance.
Acute migraine treatment
The treatment of acute migraine attacks during perimenopause and menopause is essentially the same as at younger ages. Triptans, NSAIDs, antiemetics, and newer agents (gepants, ditans) all have established evidence. The choice depends on attack frequency, severity, response to prior medications, and cardiovascular and other contraindications. Triptans have specific cardiovascular contraindications that become more relevant in midlife; review your cardiovascular history with your prescriber.
Preventive treatment
Menopause is not a disease — it's a planned change, like puberty. And just like puberty, we should be educated on what's to come years in advance, rather than the current practice of leaving people on their own with bothersome symptoms and too much conflicting information.
For women with frequent migraines (more than 4-6 attacks per month or significantly disabling attacks), preventive medication is reasonable. Options with established evidence include certain beta-blockers, topiramate, certain antidepressants, anti-CGRP monoclonal antibodies, and OnabotulinumtoxinA injections for chronic migraine. Each has its own profile of benefits, side effects, and considerations specific to midlife.
Lifestyle
The same lifestyle interventions that help fatigue and joint pain — consistent sleep, exercise, hydration, stress management — also reduce headache frequency. Caffeine plays a complex role: regular moderate caffeine is benign or modestly helpful for many; escalating use to manage poor sleep produces rebound headaches. Identifying and managing your specific triggers (alcohol, certain foods, missed meals, dehydration, weather changes, intense exertion at unaccustomed levels) reduces baseline frequency.
What doesn’t reliably help
Most “headache” supplements. Magnesium has modest evidence for migraine prevention; riboflavin (vitamin B2) and coenzyme Q10 have small trials with mixed results. Feverfew and butterbur have small evidence bases, with safety concerns for some butterbur preparations.
Oral combined contraceptives for perimenopausal symptom control if you have migraine with aura. The combination of migraine with aura and oral combined estrogen-progestin contraceptives carries elevated stroke risk and should be avoided.
Heavy daily over-the-counter analgesic use. Frequent use of acetaminophen, NSAIDs, or combination analgesics (more than 10-15 days per month) can produce medication-overuse headache that paradoxically worsens the underlying headache disorder.
When to talk to your doctor — and when to go to the ER
Most menopause-related headaches are managed in primary care or with a menopause-specialized clinician or neurologist. Certain features should prompt immediate evaluation:
“Worst headache of your life” or sudden thunderclap onset
Headache with fever, neck stiffness, or rash
Headache with new neurological symptoms (weakness, numbness, vision changes, difficulty speaking, confusion)
Headache after head injury
Progressive worsening over days or weeks
New headache type in someone over 50 with no prior headache history
Headache associated with seizure
Headache with significant change in character or pattern
These warrant emergency evaluation rather than waiting for a clinic visit. For non-urgent but concerning changes — increasing frequency, change in character, new aura features, headaches that don’t respond to usual treatment — schedule with your clinician. Our talking to your doctor guide covers how to structure that conversation.
What this means for you
For women whose migraines have worsened during perimenopause, the good news is that for most women the trajectory improves once hormones stabilize in postmenopause. The harder news is that perimenopause itself can be a years-long stretch of difficult headache management. A reasonable approach: track patterns (the connections to cycles, sleep, vasomotor symptoms are often clearer in retrospect), treat the modifiable contributors, and consider transdermal estrogen if you’re a candidate and your headache pattern suggests hormonal sensitivity.
For broader context, our how long menopause lasts and stages of menopause guides cover the timeline of the transition.
Frequently asked questions
Do menopause headaches go away after menopause?
For many women with hormone-sensitive migraine, yes — attack frequency often decreases substantially in postmenopause once estrogen levels stabilize. Tension-type headaches are more variable and depend on whether the upstream contributors (sleep, mood, stress) are addressed.
Can HRT help or worsen menopause headaches?
Both, depending on formulation. Transdermal estrogen at a stable dose often improves hormonally driven migraine by eliminating the cyclic estrogen drops that trigger attacks. Oral estrogen produces more variable levels and can sometimes worsen headaches. For women with migraine, transdermal delivery is generally preferred.
Is it safe to take HRT if I have migraine with aura?
Most current guidelines do not consider migraine with aura an absolute contraindication to transdermal menopausal hormone therapy, which uses lower doses and a delivery route with less impact on coagulation than oral combined contraceptives. This is worth discussing with a clinician familiar with current evidence rather than relying on older blanket guidance about migraine and estrogen.
Why are my headaches worse during perimenopause but better between cycles?
Hormonally sensitive migraines often cluster around the estrogen drops associated with cycles. During perimenopause, those drops happen more often and less predictably. The pattern typically improves once cycles stop entirely.
Should I see a neurologist or my regular doctor?
For new headaches or significant change in pattern in midlife, a neurologist or headache specialist is reasonable. For an established headache pattern that’s evolving as expected during the transition, your primary care or menopause-specialized clinician is usually sufficient as long as the workup is straightforward.
What headache patterns are emergencies?
“Worst headache ever,” sudden thunderclap onset, headache with fever and neck stiffness, headache with new neurological symptoms (weakness, numbness, vision changes, speech difficulty), headache after head injury, or progressive worsening over days warrant emergency evaluation.
Sources
The Menopause Society. The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. 2022;29(7):767-794.
National Institute for Health and Care Excellence. Menopause: identification and management (NG23). Updated November 2024.
MacGregor EA. Migraine, menopause and hormone replacement therapy. Post Reproductive Health. 2018;24(1):11-18.
Pavlović JM, Allshouse AA, Santoro NF, et al. Sex hormones in women with and without migraine: evidence of migraine-specific hormone profiles. Neurology. 2016;87(1):49-56.
The Menopause Society. The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society. Menopause. 2023;30(6):573-590.
Disclaimer
This article is for educational purposes and does not constitute medical advice. Always consult a qualified healthcare provider for guidance on your specific situation. Prescription medications referenced in this article (hormone therapy, triptans, gepants, ditans, beta-blockers, topiramate, anti-CGRP agents, OnabotulinumtoxinA) require evaluation by a clinician, are not appropriate for everyone, and have specific contraindications. Sudden severe headache, headache with new neurological symptoms, or any “worst headache ever” warrants emergency evaluation.




